GlycanAge (Glycan-Based Biological Age Test)

GlycanAge represents a novel approach to biological age assessment that analyzes the glycosylation patterns of immunoglobulin G (IgG) antibodies in blood plasma. Research indicates that these sugar structures attached to antibodies change predictably with age, with pro-inflammatory glycan patterns increasing while anti-inflammatory structures decrease over time. Studies suggest this reflects underlying immune system aging and chronic inflammation processes that may be more indicative of biological rather than chronological age.

The test involves a simple blood draw that is analyzed using advanced chromatography techniques to measure specific glycan structures. Research has shown correlations between GlycanAge results and various health outcomes, including cardiovascular disease risk and overall mortality. While the field is relatively new, studies suggest that glycan analysis may provide unique insights into immune system aging that complement other biological age markers.

As a purely diagnostic tool, GlycanAge carries minimal risk beyond standard blood collection procedures. However, the clinical utility and accuracy of glycan-based biological age assessment is still being established through ongoing research. The test may be particularly valuable for tracking the effects of longevity interventions over time, though more long-term studies are needed to fully validate its predictive capabilities for health outcomes and lifespan.